pharma

The first-quarter results of Swiss behemoth Kuehne + Nagel today highlighted one critical aspect for all the major asset-light logistics companies, which can be summed up by capital deployment risk – where to allocate the funds, how, when and why, based on expected returns, which can often be great on paper, but less so in reality.

In this respect, K+N has only one big option to grow inorganically, in my view, also given the emphasis that the company, in its investor ...

Subscription required for Premium stories

In order to view the entire article please login with a valid subscription below or register an account and subscribe to Premium

Or buy full access to this story only for £15.00

Please login to activate the purchase link or sign up here to register an account

Premium subscriber
New Premium subscriber REGISTER

Comment on this article


You must be logged in to post a comment.